Viking Therapeutics, Inc. (VKTX)
37.48
-0.50
(-1.32%)
USD |
NASDAQ |
Dec 09, 15:37
Viking Therapeutics Shareholders Equity (Quarterly): 713.03M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Eli Lilly & Co. | 23.79B |
| Pfizer Inc. | 92.80B |
| Amgen, Inc. | 9.619B |
| Altimmune, Inc. | 185.60M |
| Terns Pharmaceuticals, Inc. | 284.07M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 739.42M |
| Total Liabilities (Quarterly) | 26.38M |
| Debt to Equity Ratio | 0.0011 |
| Current Ratio | 28.34 |
| Net Debt Paydown Yield | 0.00% |